Commonwealth Equity Services’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-397
Closed -$333K 3658
2021
Q3
$333K Sell
397
-50
-11% -$50.7K ﹤0.01% 2811
2021
Q2
$567K Sell
447
-45
-9% -$50.8K ﹤0.01% 2363
2021
Q1
$540K Sell
492
-67
-12% -$88.5K ﹤0.01% 2273
2020
Q4
$798K Sell
559
-11
-2% -$11.7K ﹤0.01% 1807
2020
Q3
$402K Sell
570
-22
-4% -$16K ﹤0.01% 2125
2020
Q2
$414K Buy
+592
New +$342K ﹤0.01% 2036
2020
Q1
Sell
-339
Closed -$212K 2835
2019
Q4
$212K Buy
+339
New +$166K ﹤0.01% 2575

Other funds holding CDLX

Commonwealth Equity Services's CDLX Position: Q4 2021 in Review

Commonwealth Equity Services sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 397 shares — an estimated $333K sold.

Commonwealth Equity Services first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $798K in Q4 2020. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • Commonwealth Equity Services reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 397 Cardlytics shares in Q4 2021, an estimated $333K.
  • Commonwealth Equity Services first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Commonwealth Equity Services's Cardlytics position peaked at $798K in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.